Answers are grounded in this paper and cite their sources.
同種抗原となるヒト血小板抗原-15(Human platelet antigen-15:HPA-15)は血小板膜表面のCD109上に発現しており,これに対する血小板抗体は血小板輸血不応(Platelet transfusion refractoriness:PTR)や新生児血小板減少症(Neonatal alloimmune thrombocytopenia:NAIT)の原因となり得る.しかし,本邦で広く用いられている抽出抗原を用いたMixed passive hemagglutination法(MPHA法)では,HPA-15抗体を検出することは難しく,HLA抗体を有する患者では更に解析が困難である.
No takes yet. Share an insight, caveat, or question.
Okayama et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: